Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics

The Biology and Genetics of Andersen-Tawil Syndrome

At a Glance

Andersen-Tawil syndrome is a rare genetic condition in which potassium-channel changes can disrupt the electrical activity of the heart and muscles, causing episodic weakness or paralysis and abnormal rhythms; KCNJ2 is the main known gene, but some cases have no identified mutation in known genes.

Andersen-Tawil Syndrome (ATS) is an incredibly rare genetic condition, affecting approximately 1 person in every million [1]. It is classified as a channelopathy, a group of diseases caused by “glitches” in the microscopic tunnels (channels) that allow electrically charged particles, like potassium, to move in and out of cells [2]. Because these channels are essential for the electrical signals that make your heart beat and your muscles move, a defect can lead to symptoms in both areas simultaneously.

The Classic Triad

Doctors often look for a “classic triad” of three distinct types of symptoms to help diagnose ATS [3]. However, it is vital to understand that these symptoms are variably expressed. This means that not everyone with the condition will have all three features, even among members of the same family who share the exact same genetic mutation [4]. Many people with a confirmed genetic diagnosis do not show all three parts of the triad [5].

The three pillars of the triad are:

  1. Episodic Muscle Weakness: Also known as periodic paralysis, these are temporary bouts of muscle weakness or even total paralysis. These episodes can last from minutes to days and are often triggered by resting after physical activity [4][2].
  2. Cardiac Arrhythmias: Irregular heart rhythms, specifically those affecting the lower chambers of the heart (ventricles). Common findings include ventricular ectopy (extra heartbeats) and a very specific rhythm called bidirectional ventricular tachycardia, where the heart’s electrical signal appears to “flip” back and forth on an ECG [3][1].
  3. Physical Features: Subtle differences in how the face and skeleton develop. These are often mild and might include a small lower jaw (micrognathia), low-set ears, widely spaced eyes, or a permanent curve in the fifth finger (clinodactyly) [2][6].

The Genetics: ATS1 vs. ATS2

ATS is primarily an autosomal dominant condition, meaning a person only needs one copy of the changed gene from one parent to have the syndrome [1]. While it is often inherited, many cases are de novo, meaning the mutation happened for the first time in that individual [7].

There are two known genetic categorizations, though some cases remain a mystery:

  • ATS1 (KCNJ2): This is the most established cause. It is caused by a pathogenic variant (mutation) in the KCNJ2 gene, which provides instructions for building the Kir2.1 potassium channel [1][8].
  • ATS2 (KCNJ5): A much rarer form. It involves the KCNJ5 gene, which affects a different but related potassium channel called Kir3.4 [1][9]. Because this is so rare, variants must be carefully classified to ensure they truly cause ATS.
  • Unknown Causes: A significant portion of people who meet the clinical criteria for ATS do not have a mutation in either known gene. Researchers believe there are other, yet-to-be-discovered genes that can cause the same symptoms [10].

Biological Mechanism: Why Muscles and Heart?

To understand why one genetic “glitch” affects both the heart and the skeletal muscles, you have to look at the resting membrane potential. Every cell in your body acts like a tiny battery with a specific electrical charge. Potassium channels like Kir2.1 act as “stabilizers” that help the cell maintain its resting charge so it doesn’t fire off an electrical signal at the wrong time [8][11].

In ATS, these channels don’t work correctly. This leads to two main problems:

  • In the Heart: Without enough “stabilizing” potassium current, the heart cells become electrically unstable. They may take too long to reset after a beat or may fire unexpectedly, leading to the extra beats and dangerous rhythms seen in ATS [12][3].
  • In the Muscles: The loss of potassium current makes it difficult for muscle cells to maintain the correct electrical balance. When the balance is lost, the muscle fiber becomes “inexcitable”—it simply cannot respond to the signal from your brain to move, resulting in temporary paralysis [13][14].

The physical features (the third part of the triad) are less understood, but a plausible biological hypothesis is that these potassium channels also play a role in how bones and tissues signal to each other while a baby is developing in the womb [2]. Because the channel is less active, those growth signals may be slightly altered, leading to the characteristic physical traits.

Common questions in this guide

What causes Andersen-Tawil syndrome?
Andersen-Tawil syndrome is caused by a change in a gene involved in potassium channels, most often KCNJ2 and more rarely KCNJ5. Some people with the characteristic clinical features do not have a change in either known gene, so researchers suspect that additional genes may be involved.
Does everyone with Andersen-Tawil syndrome have the full triad?
No, the three features are variably expressed. A person may have muscle weakness or paralysis, abnormal heart rhythms, facial or skeletal features, or a combination of these findings.
Why can Andersen-Tawil syndrome affect both the heart and muscles?
Potassium channels help heart and muscle cells maintain their normal electrical charge. When these channels do not work properly, heart cells can produce extra or abnormal beats, while muscle fibers may temporarily fail to respond to movement signals.
What is the difference between ATS1 and ATS2?
ATS1 is the better-established form and is linked to a disease-causing change in KCNJ2, the gene that helps make the Kir2.1 potassium channel. ATS2 is much rarer and involves KCNJ5, which affects the related Kir3.4 channel.
Can a negative genetic test rule out Andersen-Tawil syndrome?
No. Some people who meet the clinical criteria do not have an identified change in KCNJ2 or KCNJ5, so a negative result does not completely exclude the condition. A genetics or heart specialist can interpret the result alongside symptoms, family history, and heart testing.
How is Andersen-Tawil syndrome passed through families?
Andersen-Tawil syndrome is usually autosomal dominant, which means one disease-causing copy of a gene can be enough to cause the condition. Some cases arise de novo, meaning the change is new in that person, and a genetic counselor can explain the specific chance of passing a known variant to a child.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my family history and symptoms, which genetic test is most appropriate for me?
  2. 2.If I have a KCNJ2 or KCNJ5 mutation, what is the exact risk of passing this on to my children?
  3. 3.Since the triad isn't always complete, which specific skeletal or facial features should we be looking for in my case?
  4. 4.How does the potassium channel defect in my specific mutation affect both my heart and my muscles?
  5. 5.If my genetic testing comes back negative, does that completely rule out Andersen-Tawil Syndrome?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Andersen-Tawil Syndrome: A Comprehensive Review.

    Pérez-Riera AR, Barbosa-Barros R, Samesina N, et al.

    Cardiology in review 2021; (29(4)):165-177 doi:10.1097/CRD.0000000000000326.

    PMID: 32947483
  2. 2

    Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.

    Vivekanandam V, Männikkö R, Skorupinska I, et al.

    Brain : a journal of neurology 2022; (145(6)):2108-2120 doi:10.1093/brain/awab445.

    PMID: 34919635
  3. 3

    Diagnostic and therapeutic challenges in Andersen-Tawil syndrome.

    Jacobsen SB, van der Werf C, van der Kooi AJ, et al.

    Heart rhythm 2026; doi:10.1016/j.hrthm.2026.09.020.

    PMID: 42754000
  4. 4

    Clinical and neurophysiological variability in Andersen-Tawil syndrome.

    Kokubun N, Aoki R, Nagashima T, et al.

    Muscle & nerve 2019; (60(6)):752-757 doi:10.1002/mus.26705.

    PMID: 31509255
  5. 5

    Phenotypical variability and atypical presentations in a French cohort of Andersen-Tawil syndrome.

    Villar-Quiles RN, Sternberg D, Tredez G, et al.

    European journal of neurology 2022; (29(8)):2398-2411 doi:10.1111/ene.15369.

    PMID: 35460302
  6. 6

    Multisystemic Assessment in Andersen-Tawil Syndrome: Report of Eighteen Individuals.

    Gnazzo M, Parlapiano G, Morlino S, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(12)) doi:10.3390/diagnostics16121876.

    PMID: 42351535
  7. 7

    Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide.

    Gupta A, Iyadurai S, Roggenbuck J, LoRusso S

    Neuromuscular disorders : NMD 2021; (31(7)):656-659 doi:10.1016/j.nmd.2021.04.001.

    PMID: 34078557
  8. 8

    Opening closed inward rectifier potassium channel doors.

    Stary-Weinzinger A, Kaiser F, van der Heyden MAG, Bendahhou S

    British journal of pharmacology 2026; (183(10)):2197-2218 doi:10.1111/bph.70374.

    PMID: 41713407
  9. 9

    Familial periodic paralysis associated with a rare KCNJ5 variant that supposed to have incomplete penetrance.

    Hiraide T, Fukumura S, Yamamoto A, et al.

    Brain & development 2021; (43(3)):470-474 doi:10.1016/j.braindev.2020.10.010.

    PMID: 33199157
  10. 10

    Distinctive facial features in Andersen-Tawil syndrome: A three-dimensional stereophotogrammetric analysis.

    Dolci C, Sansone VA, Gibelli D, et al.

    American journal of medical genetics. Part A 2021; (185(3)):781-789 doi:10.1002/ajmg.a.62040.

    PMID: 33369085
  11. 11

    Atomic-level investigation of KCNJ2 mutations associated with ventricular arrhythmic syndrome phenotypes.

    Munawar S, Anderson CL, Reilly L, et al.

    Scientific reports 2025; (15(1)):11290 doi:10.1038/s41598-025-95062-2.

    PMID: 40175568
  12. 12

    Kir2.1 dysfunction at the sarcolemma and the sarcoplasmic reticulum causes arrhythmias in a mouse model of Andersen-Tawil syndrome type 1.

    Macías Á, González-Guerra A, Moreno-Manuel AI, et al.

    Nature cardiovascular research 2022; (1(10)):900-917 doi:10.1038/s44161-022-00145-2.

    PMID: 39195979
  13. 13

    Potassium-sensitive loss of muscle force in the setting of reduced inward rectifier K+ current: Implications for Andersen-Tawil syndrome.

    Elia N, Quiñonez M, Wu F, et al.

    Proceedings of the National Academy of Sciences of the United States of America 2025; (122(13)):e2418021122 doi:10.1073/pnas.2418021122.

    PMID: 40138348
  14. 14

    Mechanisms underlying the distinct K+ dependencies of periodic paralysis.

    Foy BD, Dupont C, Walker PV, et al.

    The Journal of general physiology 2025; (157(3)) doi:10.1085/jgp.202413610.

    PMID: 39903205

This page explains the genetics and biology of Andersen-Tawil syndrome for informational purposes only and does not constitute medical advice. A geneticist, cardiologist, or neurologist can interpret your symptoms and test results.

Get notified when new evidence is published on Andersen-Tawil syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.